Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe
The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2009
by Parirenyatwa Hospital.
Recruitment status was Active, not recruiting
Study NCT00834457 Information provided by Parirenyatwa Hospital
First Received on February 2, 2009. No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
AIDS-Related Kaposi's Sarcoma
Additional conditions recognized in this trial
AIDS-Related Opportunistic Infections
Sarcoma
Sarcoma, Kaposi
More general conditions related to this trial
DNA Virus Infections
Herpesviridae Infections
HIV Infections
Immune System Diseases
Immunologic Deficiency Syndromes
Infection
Lentivirus Infections
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Connective and Soft Tissue
Neoplasms, Vascular Tissue
Opportunistic Infections
Parasitic Diseases
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Interventions listed in this trial
abacavir/3TC/zidovudine
Additional drug interventions recognized in this trial
Abacavir
Lamivudine
Lopinavir
Ritonavir
Zidovudine
More general drug interventions related to this trial
Anti-HIV Agents
Anti-Infective Agents
Anti-Retroviral Agents
Antimetabolites
Antiviral Agents
Enzyme Inhibitors
HIV Protease Inhibitors
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Protease Inhibitors
Reverse Transcriptase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Parirenyatwa Hospital
University of Colorado, Denver
GlaxoSmithKline
Abbott
Back to top of Main Content
